1. 317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumors. (9th November 2020) Authors: Emens, Leisha; Beeram, Muralidhar; Hamilton, Erika; Piha-Paul, Sarina; Odegard, Valerie; Hamke, Sue; Hunder, Naomi; Klempner, Samuel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumors. (9th November 2020) Authors: Emens, Leisha; Beeram, Muralidhar; Hamilton, Erika; Piha-Paul, Sarina; Odegard, Valerie; Hamke, Sue; Hunder, Naomi; Klempner, Samuel Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗